or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
More Buying Choices
Have one to sell? Sell yours here
Recombinant Antibodies for Cancer Immunotherapy: Recombinant Anti-MUC1 and Anti-ErbB2 Antibodies: Tools for Breast Cancer Detection and  Therapy
 
See larger image
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Recombinant Antibodies for Cancer Immunotherapy: Recombinant Anti-MUC1 and Anti-ErbB2 Antibodies: Tools for Breast Cancer Detection and Therapy [Paperback]

Yariv Mazor (Author)

Price: $88.00 & this item ships for FREE with Super Saver Shipping. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Want it delivered Wednesday, February 1? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for Students. Learn more


Book Description

3639145860 978-3639145861 April 22, 2009
Recombinant antibodies have made a tremendous impact on biomedical research and are increasingly being used as clinical diagnostic and therapeutic reagents. The discovery of the tumor markers, opened a new era in the development of antibody-targeted cancer therapy. This book evaluates the potential of recombinant derivatives of an anti-MUCI and an anti- ErbB2 Mabs to serve as tools for breast cancer detection and therapy. To explore the potential of Mabs in antibody-targeted cancer therapy, a novel IgG-toxin immunoconjugate is described. This work provides evidences that bivalent antibody-toxin molecules (200 kDa) are superior to the corresponding recombinant monovalent immunotoxins (69 kDa) in killing tumor cells in culture and human carcinoma xenografts in nude mice, suggesting that higher avidity and longer residence time may outweigh tumor penetration. Although many challenges must be addressed before the approaches mentioned in this book become standard tools for cancer therapy, continued research in this area will feed the clinical product pipeline and play an increasingly important role in finding the "magical bullet" for cancer.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)

Editorial Reviews

About the Author

Yariv Mazor born in Israel in 1974, son of Malka and Nisim Mazor. Received a PhD in 2005 from the Department of Biotechnology Tel-Aviv University Israel. 2006-2009 postdoctoral in Chemical Engineering, University of Texas at Austin, USA. In 2009 joined the Department of Antibody Discovery & Protein Engineering at MedImmune, inc. MD, USA.

Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject